Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

121 ARTÍCULOS , VIENDO DEL 91 AL 105

Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging

Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RD.

Neurology. 2017 Sep 26;89(13):1382-1390. doi: 10.1212/WNL.0000000000004425. Epub 2017 Aug 30.

Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.

Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.

Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (J-BIRD)

Kabeshita Y, Adachi H, Matsushita M, Kanemoto H, Sato S, Suzuki Y, Yoshiyama K, Shimomura T, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Tanaka H, Hatada Y, Hashimoto M, Nishio Y, Komori K, Tanaka T, Yokoyama K, Tanimukai S, Ikeda M, Takeda M, Mori E, Kudo T, Kazui H.

Int J Geriatr Psychiatry. 2017 Feb;32(2):222-230. doi: 10.1002/gps.4470. Epub 2016 Mar 21.

[Changes in drug management of Alzheimer's disease in nursing homes: Impact of the media campaign against specific drugs for Alzheimer's disease]

Petit AE, Mangeard H, Chazard E, Puisieux F.

Encephale. 2017 Feb;43(1):21-26. doi: 10.1016/j.encep.2015.03.006. Epub 2016 Mar 30.

Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis

Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I.

Neurologia. 2017 Oct;32(8):523-532. doi: 10.1016/j.nrl.2016.02.016. Epub 2016 Apr 26.

Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease

Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Lavikainen P, Hartikainen S, Taipale H.

Ann Med. 2017 May;49(3):230-239. doi: 10.1080/07853890.2016.1254349. Epub 2016 Nov 29.

Hearing impairment and risk of Alzheimer's disease: a meta-analysis of prospective cohort studies

Zheng Y, Fan S, Liao W, Fang W, Xiao S, Liu J.

Neurol Sci. 2017 Feb;38(2):233-239. doi: 10.1007/s10072-016-2779-3. Epub 2016 Nov 28.

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation

Snyder HM, Ahles T, Calderwood S, Carrillo MC, Chen H, Chang CH, Craft S, De Jager P, Driver JA, Fillit H, Knopman D, Lotze M, Tierney MC, Petanceska S, Saykin A, Seshadri S, Shineman D, Ganguli M.

Alzheimers Dement. 2017 Mar;13(3):267-273. doi: 10.1016/j.jalz.2016.11.002. Epub 2016 Dec 18.

Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease

Dodge HH, Zhu J, Woltjer R, Nelson PT, Bennett DA, Cairns NJ, Fardo DW, Kaye JA, Lyons DE, Mattek N, Schneider JA, Silbert LC, Xiong C, Yu L, Schmitt FA, Kryscio RJ, Abner EL; SMART data consortium.

Alzheimers Dement. 2017 Jun;13(6):613-623. doi: 10.1016/j.jalz.2016.11.003. Epub 2016 Dec 23.

Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients

Laumbacher B, Fellerhoff-Loesch B, Wank R.

Med Hypotheses. 2017 Feb;99:19-22. doi: 10.1016/j.mehy.2016.12.001. Epub 2016 Dec 5.

PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis

Xu HM, Tan L, Wan Y, Tan MS, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Jiang T, Tan L, Yu JT.

Mol Neurobiol. 2017 Mar;54(2):1187-1195. doi: 10.1007/s12035-016-9698-4. Epub 2016 Jan 28.

SORL1 Is Associated with the Risk of Late-Onset Alzheimer's Disease: a Replication Study and Meta-Analyses

Zhang CC, Wang HF, Tan MS, Wan Y, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Tan L, Jiang T, Tan L, Yu JT.

Mol Neurobiol. 2017 Apr;54(3):1725-1732. doi: 10.1007/s12035-016-9780-y. Epub 2016 Feb 13.

Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease

Han SH, Lee JH, Kim SY, Park KW, Chen C, Tripathi M, Dash A, Kubota N.

Acta Neurol Scand. 2017 Feb;135(2):252-256. doi: 10.1111/ane.12571. Epub 2016 Feb 29.

African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation

Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.

Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.

Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results

Lee KJ, Cho SJ, Kim BC, Park M, Lee JH.

Adv Ther. 2017 Feb;34(2):481-494. doi: 10.1007/s12325-016-0465-8. Epub 2016 Dec 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias